论文部分内容阅读
目的:评价重组人干扰素-α2b凝胶与保妇康栓对女性患者慢性宫颈炎的疗效。方法:选取2016年3月—2017年1月间收治的慢性宫颈炎患者128例,按照随机数字表法将其分为对照组64例和观察组64例;对照组患者给予保妇康栓治疗,观察组患者在对照组基础上加用重组人干扰素-α2b凝胶治疗,评价两组患者临床治疗后的总有效率及用药期间不良反应的发生率。结果:观察组患者治疗后的总有效率高于对照组(P<0.05),用药期间不良反应的发生率低于对照组(P<0.05)。结论:慢性宫颈炎患者的治疗采用保妇康栓与重组人干扰素-α2b凝胶,可获得更加确切的疗效,安全性较高。
Objective: To evaluate the curative effect of recombinant human interferon-α2b gel and Baofukang suppository on chronic cervicitis in female patients. Methods: A total of 128 patients with chronic cervicitis admitted from March 2016 to January 2017 were selected and divided into control group (64 cases) and observation group (64 cases) by random number table method. Patients in the control group were treated with Baofukang suppository The patients in the observation group were treated with recombinant human interferon-α2b gel on the basis of the control group, and the total effective rate and the incidence of adverse reactions after the clinical treatment in both groups were evaluated. Results: The total effective rate of observation group was higher than that of control group (P <0.05). The incidence of adverse reactions in observation group was lower than that of control group (P <0.05). Conclusion: The treatment of patients with chronic cervicitis using Baofukang suppository and recombinant human interferon-α2b gel, to obtain more precise efficacy, higher safety.